Glenmark Pharmaceuticals bags approval for Teriflunomide tablets
Glenmark Pharmaceuticals bags approval for Teriflunomide tablets

Glenmark Pharmaceuticals bags approval for Teriflunomide tablets

Shohini Nath Article rating: 5.0

The pharma major Glenmark has won final USFDA approval for Teriflunomide Tablets, 7 mg and 14 mg. The shares of the company rose 1.5 per cent in the early trade following the announcement.

ITC spikes on plans to expand dairy segment
ITC spikes on plans to expand dairy segment

ITC spikes on plans to expand dairy segment

Sanket Dewarkar Article rating: 5.0

ITC is eyeing at portfolio expansion in its food division to achieve the stated vision of achieving Rs. 1 lakh crore turnover from FMCG by 2030. The food category, which drives the fast-moving consumer durable industry, is expected to contribute around 60-65 per cent of its turnover by 2030.

Renting a house can make you crorepati in 20 years
Renting a house can make you crorepati in 20 years

Renting a house can make you crorepati in 20 years

Henil Shah Article rating: 3.8

Having your own house is a dream of every individual and leveraging savings for buying a home is very normal practice in India. But can renting a house instead of buying eventually make you crorepati? Read on to find out more.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 2.89 crore contracts with a turnover of Rs. 15,60,701.67 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 2.89 crore contracts with a turnover of Rs. 15,60,701.67 crore.

Index trend and stocks in action November 16, 2018
Index trend and stocks in action November 16, 2018

Index trend and stocks in action November 16, 2018

Karan Dsij Article rating: 5.0

Unless Nifty successfully moves past the hurdle of 10,650, we do not see any significant move in the index. On the downside, immediate support is seen around the level of 10,530, followed by 10,440.  Stocks in news: Venus Remedies, Tata Sponge Iron, SRF, Yes Bank, Lemon Tree, Infosys and Bank of Baroda.

Markets may start with minor gains
Markets may start with minor gains

Markets may start with minor gains

Karan Dsij Article rating: 5.0

The diminishing prospects of an all-out trade war and the rupee rallies to two-month high to close below 72-mark against the US dollar are a big boost for the Indian markets and thus we could see an optimistic start to the day. The SGX Nifty Index Future has nearly gained 0.38 per cent, suggesting Nifty may open around the level of 10,663.  

Bharat Forge likely to witness fireworks above Rs. 637
Bharat Forge likely to witness fireworks above Rs. 637

Bharat Forge likely to witness fireworks above Rs. 637

Vinayak Gangule Article rating: 3.5

In the short-term, Rs 575-570 is likely to act as a strong support zone. While the momentum is likely to been seen when the stock manages to sustain above the recent swing of Rs. 637 per share.

RSS
First27882789279027912793279527962797Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR